Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]

Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] was reported 5951 times

Drugs of the Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DEAFNESS PERMANENT 136 0.6939
1 ORBITAL DECOMPRESSION 14 0.6087
2 DYSTHYROID OPTIC NEUROPATHY 3 0.5000
3 AUTOPHONY 34 0.4533
4 ENDOCRINE OPHTHALMOPATHY 375 0.4320
5 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 31 0.3875
6 TOXIC GOITRE 21 0.3443
7 EYELID RETRACTION 30 0.3000
8 EXPOSURE KERATITIS 7 0.2333
9 EUSTACHIAN TUBE PATULOUS 9 0.2195
10 THYROID STIMULATING IMMUNOGLOBULIN 5 0.1613
11 MIXED DEAFNESS 11 0.1392
12 ANTI-THYROID ANTIBODY INCREASED 17 0.1349
13 ONYCHOMALACIA 11 0.0880
14 EXOPHTHALMOS 185 0.0859
15 AUDIOGRAM ABNORMAL 3 0.0750
16 POST PROCEDURAL HYPOTHYROIDISM 13 0.0613
17 DEAFNESS NEUROSENSORY 193 0.0586
18 EUSTACHIAN TUBE DYSFUNCTION 30 0.0521
19 EUSTACHIAN TUBE DISORDER 12 0.0502
20 CERUMEN REMOVAL 2 0.0500
21 DERMATOCHALASIS 6 0.0408
22 TRI-IODOTHYRONINE FREE INCREASED 7 0.0407
23 EAR DRYNESS 4 0.0381
24 CERUMEN IMPACTION 32 0.0349
25 HAIR GROWTH RATE ABNORMAL 5 0.0342
26 PRODUCT INFORMATION CONTENT COMPLAINT 9 0.0323
27 TYPE V HYPERLIPIDAEMIA 14 0.0288
28 VERY LOW DENSITY LIPOPROTEIN INCREASED 6 0.0270
29 PHYSICAL DISABILITY 118 0.0267
30 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 7 0.0259
31 ACOUSTIC STIMULATION TESTS ABNORMAL 4 0.0256
32 GINGIVAL RECESSION 49 0.0255
33 CONDUCTIVE DEAFNESS 8 0.0249
34 AUDITORY DISORDER 35 0.0246
35 DYSACUSIS 3 0.0242
36 NASAL TURBINATE HYPERTROPHY 9 0.0239
37 DEAFNESS BILATERAL 39 0.0229
38 EYELID OPERATION 6 0.0224
39 EAR DISCOMFORT 229 0.0223
40 ONYCHOCLASIS 148 0.0215
41 SYMPTOM RECURRENCE 123 0.0205
42 THYROXINE FREE INCREASED 13 0.0203
43 IMPAIRED FASTING GLUCOSE 6 0.0197
44 EUSTACHIAN TUBE OBSTRUCTION 3 0.0183
45 BILIRUBIN URINE PRESENT 2 0.0168
46 NAIL GROWTH ABNORMAL 18 0.0164
47 THYROXINE FREE DECREASED 9 0.0159
48 CONCOMITANT DISEASE AGGRAVATED 97 0.0157
49 TRI-IODOTHYRONINE FREE DECREASED 4 0.0157
50 CYSTATIN C INCREASED 2 0.0156
51 ANTI-THYROID ANTIBODY POSITIVE 7 0.0153
52 TRI-IODOTHYRONINE INCREASED 6 0.0150
53 NAIL BED DISORDER 6 0.0141
54 TINNITUS 627 0.0136
55 STRABISMUS 40 0.0136
56 CATARACT NUCLEAR 9 0.0135
57 DACRYOCYSTITIS 2 0.0130
58 HYPOGONADISM MALE 3 0.0129
59 DIPLOPIA 329 0.0127
60 EXTRAOCULAR MUSCLE DISORDER 4 0.0124
61 VASCULAR ACCESS COMPLICATION 10 0.0123
62 BLOOD CHLORIDE ABNORMAL 2 0.0123
63 LAGOPHTHALMOS 5 0.0122
64 ALTERED VISUAL DEPTH PERCEPTION 10 0.0122
65 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 5 0.0117
66 HYPOACUSIS 504 0.0117
67 CONJUNCTIVAL OEDEMA 12 0.0117
68 MEAN PLATELET VOLUME INCREASED 7 0.0116
69 THYROIDECTOMY 20 0.0115
70 DEAFNESS 294 0.0112
71 IMPAIRED QUALITY OF LIFE 159 0.0110
72 GLOBULINS INCREASED 4 0.0110
73 LID SULCUS DEEPENED 4 0.0107
74 CARBON DIOXIDE DECREASED 12 0.0104
75 POLYCYSTIC OVARIAN SYNDROME 4 0.0104
76 BLOOD ALBUMIN INCREASED 9 0.0101
77 NAIL DISORDER 87 0.0099
78 EXCESSIVE CERUMEN PRODUCTION 6 0.0097
79 ACROMEGALY 3 0.0095
80 DEAFNESS TRANSITORY 8 0.0094
81 DEAFNESS UNILATERAL 50 0.0091
82 BLOOD INSULIN INCREASED 5 0.0091
83 BRACHIAL PLEXOPATHY 2 0.0090
84 CARBON DIOXIDE INCREASED 12 0.0088
85 PRODUCT USE COMPLAINT 137 0.0087
86 ANION GAP DECREASED 3 0.0086
87 THYROXINE INCREASED 6 0.0085
88 BLOOD ALKALINE PHOSPHATASE DECREASED 8 0.0084
89 EYE SYMPTOM 3 0.0084
90 BLOOD THYROID STIMULATING HORMONE DECREASED 38 0.0084
91 LOWER URINARY TRACT SYMPTOMS 3 0.0083
92 CALCIUM IONISED DECREASED 2 0.0082
93 OTOTOXICITY 15 0.0081
94 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 7 0.0080
95 ESSENTIAL HYPERTENSION 14 0.0076
96 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 5 0.0076
97 AMENORRHOEA 133 0.0076
98 NAIL PITTING 3 0.0076
99 BREAST CALCIFICATIONS 6 0.0075
100 NASAL SEPTUM DEVIATION 14 0.0072
101 NAIL BED BLEEDING 4 0.0070
102 CHONDROMALACIA 2 0.0070
103 EAR CONGESTION 19 0.0070
104 ONYCHALGIA 7 0.0070
105 REFLUX LARYNGITIS 3 0.0068
106 OTITIS MEDIA ACUTE 5 0.0068
107 PHYSICAL PRODUCT LABEL ISSUE 8 0.0067
108 ECONOMIC PROBLEM 98 0.0065
109 MUSCLE SPASMS 1156 0.0063
110 CHALAZION 4 0.0062
111 CEREBRAL AMYLOID ANGIOPATHY 2 0.0061
112 DYSCHROMATOPSIA 5 0.0060
113 HIGH DENSITY LIPOPROTEIN INCREASED 6 0.0060
114 INFUSION SITE BRUISING 13 0.0060
115 PHARYNGEAL ABSCESS 3 0.0060
116 MEAN PLATELET VOLUME DECREASED 5 0.0060
117 MEAN CELL VOLUME DECREASED 9 0.0058
118 BLOOD CHLORIDE DECREASED 15 0.0058
119 EPISCLERITIS 4 0.0058
120 BLOOD CHLORIDE INCREASED 10 0.0058
121 TRI-IODOTHYRONINE DECREASED 3 0.0057
122 OTITIS EXTERNA 7 0.0057
123 HIGH DENSITY LIPOPROTEIN DECREASED 19 0.0057
124 CERVICAL RADICULOPATHY 4 0.0056
125 PRESBYOPIA 3 0.0054
126 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 6 0.0054
127 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 3 0.0054
128 PRODUCT SUPPLY ISSUE 38 0.0053
129 GLYCOSYLATED HAEMOGLOBIN INCREASED 133 0.0053
130 ACUTE SINUSITIS 9 0.0052
131 OPTIC NEUROPATHY 11 0.0052
132 HYPERACUSIS 19 0.0051
133 AMBLYOPIA 3 0.0051
134 DISABILITY 97 0.0049
135 OCULAR DISCOMFORT 55 0.0049
136 THYROID HORMONES INCREASED 5 0.0048
137 TASTE DISORDER 96 0.0047
138 BLOOD THYROID STIMULATING HORMONE INCREASED 43 0.0047
139 LYMPHOCYTE COUNT INCREASED 15 0.0046
140 ONYCHOLYSIS 7 0.0045
141 BODY MASS INDEX INCREASED 6 0.0044
142 INFUSION SITE RASH 6 0.0044
143 RED BLOOD CELL COUNT INCREASED 12 0.0043
144 BODY MASS INDEX DECREASED 2 0.0043
145 PRURITUS ALLERGIC 5 0.0043
146 MEAN CELL VOLUME INCREASED 11 0.0043
147 PERIORBITAL SWELLING 24 0.0042
148 SKIN TEXTURE ABNORMAL 4 0.0042
149 OBSTRUCTIVE SLEEP APNOEA SYNDROME 6 0.0041
150 MIDDLE EAR EFFUSION 9 0.0041
151 INTERCEPTED PRODUCT ADMINISTRATION ERROR 31 0.0040
152 BRONCHITIS BACTERIAL 3 0.0040
153 BASOPHIL COUNT INCREASED 3 0.0040
154 HYPERGLYCAEMIA 143 0.0039
155 EYELID DISORDER 9 0.0039
156 MONOCYTE COUNT INCREASED 14 0.0039
157 NAIL DISCOLOURATION 15 0.0038
158 DISCOMFORT 232 0.0038
159 ASPARTATE AMINOTRANSFERASE DECREASED 2 0.0038
160 THYROID HORMONES DECREASED 3 0.0037
161 INNER EAR DISORDER 4 0.0037
162 PROCEDURAL NAUSEA 3 0.0037
163 GLUCOSE TOLERANCE IMPAIRED 22 0.0037
164 BLOOD SODIUM INCREASED 10 0.0037
165 BODY FAT DISORDER 2 0.0037
166 TYPE 1 DIABETES MELLITUS 22 0.0036
167 CORNEAL ABRASION 5 0.0036
168 VEIN RUPTURE 6 0.0036
169 BODY TINEA 2 0.0036
170 EAR PAIN 69 0.0035
171 THYROTOXIC CRISIS 4 0.0035
172 PHOTOPHOBIA 66 0.0035
173 LOW DENSITY LIPOPROTEIN INCREASED 27 0.0035
174 LUMBAR RADICULOPATHY 4 0.0035
175 POSTMENOPAUSAL HAEMORRHAGE 9 0.0034
176 INFUSION SITE DISCOLOURATION 3 0.0034
177 EAR DISORDER 15 0.0033
178 VESTIBULAR DISORDER 4 0.0033
179 DIABETES MELLITUS 249 0.0033
180 BLOOD THYROID STIMULATING HORMONE ABNORMAL 6 0.0033
181 THERAPEUTIC RESPONSE DELAYED 9 0.0032
182 INFLAMMATORY BOWEL DISEASE 31 0.0032
183 RETINAL DEGENERATION 4 0.0031
184 LACRIMATION INCREASED 93 0.0031
185 MEAN CELL HAEMOGLOBIN INCREASED 5 0.0030
186 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 5 0.0030
187 EYE COLOUR CHANGE 3 0.0029
188 AUTOIMMUNE THYROIDITIS 11 0.0029
189 ONYCHOMADESIS 12 0.0029
190 VERTIGO POSITIONAL 5 0.0029
191 HAIR GROWTH ABNORMAL 19 0.0027
192 MEAN CELL HAEMOGLOBIN DECREASED 5 0.0027
193 EYE PAIN 154 0.0027
194 BENIGN NEOPLASM OF THYROID GLAND 2 0.0027
195 CONJUNCTIVITIS ALLERGIC 4 0.0027
196 ESSENTIAL TREMOR 3 0.0027
197 FOREIGN BODY SENSATION IN EYES 17 0.0027
198 THYROID FUNCTION TEST ABNORMAL 11 0.0026
199 HAEMATOCRIT INCREASED 6 0.0026
200 THYROID MASS 10 0.0026
201 SURGICAL FAILURE 3 0.0026
202 MADAROSIS 30 0.0026
203 DRY EYE 129 0.0026
204 VITILIGO 6 0.0026
205 ULCERATIVE KERATITIS 7 0.0026
206 SWELLING OF EYELID 16 0.0025
207 OPHTHALMOPLEGIA 4 0.0025
208 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 5 0.0025
209 IRIDOCYCLITIS 8 0.0025
210 CONJUNCTIVAL HYPERAEMIA 9 0.0025
211 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 3 0.0025
212 EAR HAEMORRHAGE 5 0.0025
213 VITAMIN D DEFICIENCY 24 0.0025
214 BLOOD GLUCOSE INCREASED 458 0.0024
215 EYELID MARGIN CRUSTING 7 0.0024
216 MENSTRUAL DISORDER 20 0.0024
217 RED CELL DISTRIBUTION WIDTH INCREASED 10 0.0024
218 DENTAL DISCOMFORT 2 0.0024
219 NEUTROPHIL PERCENTAGE INCREASED 3 0.0024
220 HYPERAESTHESIA TEETH 3 0.0024
221 TYMPANIC MEMBRANE PERFORATION 4 0.0024
222 HYPERTHYROIDISM 34 0.0023
223 MENOPAUSE 6 0.0023
224 EMOTIONAL DISTRESS 281 0.0023
225 EYE DISORDER 76 0.0023
226 OTORRHOEA 4 0.0023
227 BLOOD TRIGLYCERIDES ABNORMAL 2 0.0023
228 ALOPECIA 441 0.0022
229 ANION GAP INCREASED 3 0.0022
230 BLOOD CREATININE DECREASED 7 0.0022
231 INFUSION SITE PRURITUS 7 0.0022
232 NASAL DISCHARGE DISCOLOURATION 3 0.0022
233 METAMORPHOPSIA 4 0.0022
234 SINUS PAIN 5 0.0021
235 DEFORMITY 20 0.0021
236 GINGIVAL PAIN 17 0.0021
237 NASAL OBSTRUCTION 4 0.0021
238 INSULIN-LIKE GROWTH FACTOR INCREASED 3 0.0021
239 EYE SWELLING 78 0.0021
240 NAIL INFECTION 3 0.0021
241 QUALITY OF LIFE DECREASED 28 0.0021
242 HORDEOLUM 9 0.0021
243 RHINITIS ALLERGIC 9 0.0020
244 ASTHENOPIA 11 0.0020
245 BLEPHARITIS 8 0.0020
246 INTERMENSTRUAL BLEEDING 11 0.0020
247 AGEUSIA 49 0.0020
248 BLOOD GLUCOSE ABNORMAL 36 0.0019
249 RENAL MASS 4 0.0019
250 VITREOUS FLOATERS 19 0.0019
251 NEOPLASM SKIN 3 0.0019
252 EAR SWELLING 4 0.0019
253 NEURODERMATITIS 7 0.0019
254 PROTEIN TOTAL DECREASED 7 0.0019
255 AMAUROSIS FUGAX 2 0.0019
256 PARANASAL SINUS DISCOMFORT 7 0.0018
257 TEMPERATURE INTOLERANCE 19 0.0018
258 SKIN WRINKLING 5 0.0018
259 POOR VENOUS ACCESS 19 0.0018
260 OLIGOMENORRHOEA 4 0.0018
261 UPPER-AIRWAY COUGH SYNDROME 15 0.0018
262 OCULAR HYPERAEMIA 86 0.0018
263 AORTIC DILATATION 2 0.0018
264 BLOOD PRESSURE SYSTOLIC INCREASED 35 0.0018
265 TRICHORRHEXIS 5 0.0018
266 INJURY 126 0.0018
267 CHRONIC GASTRITIS 4 0.0018
268 FOOD AVERSION 3 0.0018
269 LOWER RESPIRATORY TRACT CONGESTION 3 0.0018
270 NEUTROPHIL COUNT INCREASED 18 0.0018
271 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
272 EYE OPERATION 8 0.0017
273 BLOOD PRESSURE INCREASED 265 0.0017
274 SPONDYLOLISTHESIS 3 0.0017
275 PAPILLARY THYROID CANCER 3 0.0017
276 TYPE 2 DIABETES MELLITUS 58 0.0017
277 MENOPAUSAL SYMPTOMS 4 0.0017
278 GLOMERULAR FILTRATION RATE DECREASED 21 0.0017
279 BREAST CYST 3 0.0017
280 INGROWING NAIL 4 0.0017
281 THYROID DISORDER 26 0.0017
282 MYOPIA 4 0.0017
283 IRRITABLE BOWEL SYNDROME 36 0.0017
284 SARS-COV-2 TEST POSITIVE 22 0.0017
285 PULSE ABNORMAL 4 0.0017
286 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
287 THIRST 29 0.0016
288 RETINAL TEAR 4 0.0016
289 THERAPY NON-RESPONDER 72 0.0016
290 CHRONIC SINUSITIS 6 0.0016
291 IMPATIENCE 3 0.0016
292 INFUSION SITE SWELLING 10 0.0016
293 DIABETIC KETOACIDOSIS 38 0.0016
294 EYELID PTOSIS 16 0.0016
295 GINGIVAL DISORDER 6 0.0016
296 HEAVY MENSTRUAL BLEEDING 14 0.0016
297 AORTIC ARTERIOSCLEROSIS 4 0.0016
298 DACRYOSTENOSIS ACQUIRED 2 0.0015
299 BENIGN PROSTATIC HYPERPLASIA 8 0.0015
300 VULVOVAGINAL DRYNESS 5 0.0015
301 THERAPY PARTIAL RESPONDER 24 0.0015
302 HYPOGEUSIA 3 0.0015
303 BLOOD TRIGLYCERIDES INCREASED 27 0.0015
304 VITAMIN D DECREASED 13 0.0015
305 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 108 0.0015
306 ACROCHORDON 2 0.0015
307 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 51 0.0015
308 APPETITE DISORDER 10 0.0015
309 HYPERLIPIDAEMIA 18 0.0015
310 PROTEIN TOTAL INCREASED 4 0.0015
311 DIARRHOEA HAEMORRHAGIC 14 0.0015
312 RHINITIS 12 0.0015
313 VITAMIN B12 DEFICIENCY 6 0.0015
314 ERYTHEMA OF EYELID 8 0.0015
315 MENSTRUATION DELAYED 16 0.0015
316 PRODUCT COMMUNICATION ISSUE 13 0.0015
317 EYE MOVEMENT DISORDER 10 0.0015
318 EYE DISCHARGE 15 0.0014
319 INSULIN RESISTANCE 3 0.0014
320 DRY SKIN 191 0.0014
321 EAR PRURITUS 5 0.0014
322 SLEEP DEFICIT 3 0.0014
323 APHTHOUS ULCER 11 0.0014
324 BLOOD ELECTROLYTES DECREASED 2 0.0014
325 ABNORMAL SENSATION IN EYE 6 0.0014
326 SKIN ATROPHY 8 0.0014
327 EYE INFLAMMATION 13 0.0014
328 BLOOD PARATHYROID HORMONE DECREASED 2 0.0013
329 APRAXIA 2 0.0013
330 AXILLARY PAIN 2 0.0013
331 SNORING 5 0.0013
332 ASTIGMATISM 2 0.0013
333 EOSINOPHIL COUNT INCREASED 11 0.0013
334 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
335 DIVERTICULITIS 36 0.0013
336 INFUSION SITE EXTRAVASATION 8 0.0013
337 DISCOURAGEMENT 3 0.0013
338 EYE PRURITUS 43 0.0013
339 ESCHERICHIA BACTERAEMIA 3 0.0013
340 BLEPHAROSPASM 8 0.0013
341 PANCREATITIS CHRONIC 3 0.0013
342 POLYDIPSIA 5 0.0013
343 EOSINOPHIL COUNT DECREASED 3 0.0013
344 URINARY HESITATION 3 0.0013
345 SPINAL OSTEOARTHRITIS 11 0.0013
346 WEIGHT ABNORMAL 3 0.0012
347 MYASTHENIA GRAVIS 10 0.0012
348 MAJOR DEPRESSION 9 0.0012
349 ANTINUCLEAR ANTIBODY POSITIVE 4 0.0012
350 ANXIETY 350 0.0012
351 COSTOCHONDRITIS 2 0.0012
352 FACET JOINT SYNDROME 4 0.0012
353 GOITRE 5 0.0012
354 THERAPY CHANGE 12 0.0012
355 INFUSION SITE HAEMORRHAGE 4 0.0012
356 HAIR DISORDER 10 0.0012
357 DYSGEUSIA 90 0.0012
358 BLOOD UREA INCREASED 20 0.0012
359 BREAST MASS 8 0.0012
360 DYSLIPIDAEMIA 6 0.0012
361 HEPATIC CYST 4 0.0012
362 BOWEL MOVEMENT IRREGULARITY 9 0.0012
363 HEART RATE DECREASED 41 0.0012
364 WEIGHT DECREASED 321 0.0011
365 DIVERTICULUM INTESTINAL 5 0.0011
366 MELANOCYTIC NAEVUS 5 0.0011
367 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
368 HAEMORRHAGIC DIATHESIS 4 0.0011
369 FACIAL PAIN 10 0.0011
370 NASAL DRYNESS 7 0.0011
371 BLOOD PRESSURE ABNORMAL 22 0.0011
372 ABDOMINAL RIGIDITY 3 0.0011
373 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
374 HEART RATE ABNORMAL 6 0.0011
375 BLOOD CHOLESTEROL DECREASED 2 0.0011
376 OBESITY 17 0.0011
377 JOINT LOCK 3 0.0011
378 FATIGUE 822 0.0011
379 VISION BLURRED 144 0.0010
380 MENSTRUATION IRREGULAR 28 0.0010
381 ADRENAL DISORDER 2 0.0010
382 HYPERTONIC BLADDER 3 0.0010
383 VOMITING PROJECTILE 3 0.0010
384 HYPOTHYROIDISM 33 0.0010
385 LUMBAR SPINAL STENOSIS 3 0.0010
386 BLOOD TESTOSTERONE DECREASED 7 0.0010
387 TOOTH DISCOLOURATION 3 0.0010
388 SKIN ODOUR ABNORMAL 4 0.0010
389 HAEMATOCRIT DECREASED 20 0.0010
390 EYE IRRITATION 58 0.0010
391 FORMICATION 7 0.0010
392 CEREBRAL ATROPHY 4 0.0010
393 DEFAECATION URGENCY 7 0.0010
394 PRODUCT STORAGE ERROR 87 0.0010
395 GALLBLADDER OPERATION 4 0.0010
396 IRITIS 3 0.0010
397 BREAST DISORDER 2 0.0010
398 DIABETIC FOOT 3 0.0010
399 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
400 ADVERSE DRUG REACTION 85 0.0009
401 MUSCLE FATIGUE 4 0.0009
402 POLLAKIURIA 39 0.0009
403 ANAL FISSURE 5 0.0009
404 LOOSE TOOTH 3 0.0009
405 OVERWEIGHT 5 0.0009
406 DRY MOUTH 75 0.0009
407 BLOOD POTASSIUM INCREASED 15 0.0009
408 HERPES SIMPLEX 6 0.0009
409 BLOOD CALCIUM INCREASED 8 0.0009
410 VERTIGO 55 0.0009
411 BLOOD SODIUM DECREASED 17 0.0009
412 BACTERIAL TEST POSITIVE 2 0.0009
413 MYALGIA 152 0.0009
414 BLOOD CALCIUM DECREASED 10 0.0009
415 HAEMATOCHEZIA 49 0.0009
416 DIABETIC RETINOPATHY 3 0.0009
417 CERVICAL VERTEBRAL FRACTURE 3 0.0009
418 FRUSTRATION TOLERANCE DECREASED 7 0.0009
419 TENDERNESS 9 0.0009
420 RENAL FUNCTION TEST ABNORMAL 4 0.0009
421 HEPATIC STEATOSIS 16 0.0009
422 CAROTID ARTERY STENOSIS 3 0.0009
423 OSTEOPENIA 13 0.0009
424 UMBILICAL HERNIA 4 0.0009
425 POLYURIA 7 0.0009
426 FLANK PAIN 8 0.0009
427 HANGOVER 3 0.0009
428 VISUAL IMPAIRMENT 105 0.0008
429 VULVOVAGINAL PAIN 4 0.0008
430 VISUAL FIELD DEFECT 6 0.0008
431 SINUS BRADYCARDIA 8 0.0008
432 BURSITIS 10 0.0008
433 HAIR TEXTURE ABNORMAL 11 0.0008
434 PHARYNGEAL SWELLING 8 0.0008
435 DERMAL CYST 2 0.0008
436 SENSITIVE SKIN 6 0.0008
437 WOUND HAEMORRHAGE 3 0.0008
438 HEADACHE 499 0.0008
439 PAROSMIA 6 0.0008
440 DRY THROAT 8 0.0008
441 INFUSION RELATED REACTION 52 0.0008
442 ERECTILE DYSFUNCTION 20 0.0008
443 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
444 VARICOSE VEIN 4 0.0008
445 TOOTHACHE 14 0.0008
446 HAEMORRHOIDS 15 0.0008
447 EXOSTOSIS 7 0.0008
448 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 138 0.0008
449 PROSTATOMEGALY 3 0.0008
450 NYSTAGMUS 4 0.0008
451 ANIMAL BITE 2 0.0007
452 EPISTAXIS 56 0.0007
453 ABDOMINAL MASS 2 0.0007
454 ENURESIS 3 0.0007
455 SINUS CONGESTION 10 0.0007
456 BLOOD URINE PRESENT 14 0.0007
457 UVEITIS 10 0.0007
458 BLOOD PHOSPHORUS INCREASED 2 0.0007
459 BLOOD GLUCOSE FLUCTUATION 8 0.0007
460 GASTROINTESTINAL PAIN 8 0.0007
461 GLAUCOMA 14 0.0007
462 LARGE INTESTINE POLYP 5 0.0007
463 AUTOIMMUNE DISORDER 7 0.0007
464 BALANCE DISORDER 62 0.0007
465 DIARRHOEA 462 0.0007
466 ABDOMINAL DISCOMFORT 120 0.0007
467 ANAL HAEMORRHAGE 2 0.0007
468 BODY TEMPERATURE DECREASED 7 0.0007
469 CATARACT 42 0.0007
470 INFUSION SITE PAIN 9 0.0007
471 HIATUS HERNIA 9 0.0007
472 BLOOD URIC ACID INCREASED 4 0.0007
473 SKIN WARM 4 0.0007
474 BLOOD PARATHYROID HORMONE INCREASED 2 0.0007
475 GASTROINTESTINAL DISORDER 61 0.0007
476 HEAD DISCOMFORT 12 0.0007
477 BLOOD CREATINE INCREASED 3 0.0007
478 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
479 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
480 WHEELCHAIR USER 3 0.0007
481 ORAL PAIN 15 0.0007
482 URINE ABNORMALITY 3 0.0007
483 GINGIVAL BLEEDING 9 0.0007
484 HAEMOGLOBIN INCREASED 3 0.0007
485 AORTIC ANEURYSM 5 0.0007
486 ISCHAEMIA 3 0.0007
487 PIGMENTATION DISORDER 4 0.0006
488 BRADYCARDIA 34 0.0006
489 BRAIN FOG 10 0.0006
490 SKIN ABRASION 3 0.0006
491 CONDITION AGGRAVATED 191 0.0006
492 ANOSMIA 9 0.0006
493 EYE INFECTION 7 0.0006
494 CARDIAC FLUTTER 4 0.0006
495 HYPERTENSION 131 0.0006
496 MUSCLE DISORDER 5 0.0006
497 MUSCLE TIGHTNESS 10 0.0006
498 HORMONE LEVEL ABNORMAL 3 0.0006
499 ENCEPHALOPATHY 15 0.0006
500 PANCREATIC DISORDER 3 0.0006
501 NECK PAIN 34 0.0006
502 LIGAMENT SPRAIN 6 0.0006
503 WALKING AID USER 4 0.0006
504 PHOTOSENSITIVITY REACTION 10 0.0006
505 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
506 DYSMENORRHOEA 8 0.0006
507 PROTEIN URINE PRESENT 3 0.0006
508 BLOOD CHOLESTEROL INCREASED 28 0.0006
509 VEIN DISORDER 3 0.0006
510 OSTEOARTHRITIS 25 0.0006
511 PRODUCT QUALITY ISSUE 80 0.0006
512 PAIN 360 0.0006
513 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
514 THYROID CANCER 7 0.0006
515 BLOOD MAGNESIUM DECREASED 5 0.0006
516 PERIORBITAL OEDEMA 3 0.0006
517 NAUSEA 453 0.0006
518 CATATONIA 3 0.0006
519 MIGRAINE 54 0.0006
520 SEASONAL ALLERGY 8 0.0006
521 ILLNESS 58 0.0006
522 DIVERTICULUM 4 0.0006
523 APPENDICECTOMY 2 0.0006
524 KIDNEY INFECTION 11 0.0006
525 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
526 RED BLOOD CELL COUNT DECREASED 16 0.0006
527 COLITIS ULCERATIVE 25 0.0006
528 SINUS DISORDER 11 0.0006
529 PALPITATIONS 65 0.0006
530 DEHYDRATION 74 0.0006
531 THERAPY INTERRUPTED 39 0.0005
532 ROTATOR CUFF SYNDROME 7 0.0005
533 RETINAL DETACHMENT 5 0.0005
534 HYPERKERATOSIS 3 0.0005
535 ILL-DEFINED DISORDER 33 0.0005
536 BLINDNESS TRANSIENT 4 0.0005
537 TOOTH DISORDER 12 0.0005
538 GAIT INABILITY 18 0.0005
539 BONE DENSITY ABNORMAL 2 0.0005
540 ADVERSE EVENT 49 0.0005
541 TOOTH LOSS 11 0.0005
542 CHEMOTHERAPY 2 0.0005
543 UNEVALUABLE EVENT 40 0.0005
544 ADVERSE REACTION 7 0.0005
545 SLEEP APNOEA SYNDROME 10 0.0005
546 GASTROOESOPHAGEAL REFLUX DISEASE 42 0.0005
547 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
548 HERPES VIRUS INFECTION 3 0.0005
549 MUSCLE TWITCHING 12 0.0005
550 MOUTH SWELLING 3 0.0005
551 CONCUSSION 4 0.0005
552 EYELID OEDEMA 6 0.0005
553 NASAL CONGESTION 30 0.0005
554 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
555 LYMPHOCYTE COUNT DECREASED 9 0.0005
556 DYSPHAGIA 48 0.0005
557 RESPIRATORY TRACT CONGESTION 8 0.0005
558 MACULAR DEGENERATION 6 0.0005
559 SCIATICA 8 0.0005
560 DIZZINESS 250 0.0005
561 NOCTURIA 6 0.0005
562 INGUINAL HERNIA 3 0.0005
563 BLINDNESS 20 0.0005
564 LETHARGY 28 0.0005
565 LIMB DISCOMFORT 15 0.0005
566 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
567 COLITIS 18 0.0005
568 MOUTH ULCERATION 10 0.0005
569 PHOTOPSIA 3 0.0005
570 AORTIC VALVE INCOMPETENCE 2 0.0005
571 INTRAOCULAR PRESSURE INCREASED 6 0.0005
572 ABSCESS LIMB 2 0.0005
573 FACIAL PARALYSIS 4 0.0005
574 DYSPEPSIA 46 0.0005
575 CONTUSION 45 0.0005
576 SKIN HYPERPIGMENTATION 4 0.0005
577 MUSCLE STRAIN 4 0.0005
578 TENDON DISORDER 3 0.0005
579 SKIN LACERATION 5 0.0005
580 PRODUCT PREPARATION ISSUE 3 0.0005
581 DECREASED APPETITE 106 0.0005
582 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
583 ABDOMINAL ABSCESS 2 0.0005
584 TENDONITIS 7 0.0005
585 EAR INFECTION 12 0.0005
586 SKIN MASS 3 0.0004
587 POST-TRAUMATIC STRESS DISORDER 3 0.0004
588 FREQUENT BOWEL MOVEMENTS 12 0.0004
589 FEEDING DISORDER 9 0.0004
590 OROPHARYNGEAL DISCOMFORT 4 0.0004
591 MITRAL VALVE INCOMPETENCE 5 0.0004
592 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
593 PRODUCT AVAILABILITY ISSUE 10 0.0004
594 BLOOD PRESSURE DECREASED 29 0.0004
595 IRON DEFICIENCY ANAEMIA 4 0.0004
596 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
597 OROPHARYNGEAL PAIN 40 0.0004
598 ORAL DISCOMFORT 6 0.0004
599 FEELING COLD 12 0.0004
600 BLINDNESS UNILATERAL 6 0.0004
601 ARTERIOSCLEROSIS 4 0.0004
602 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
603 FEAR OF INJECTION 3 0.0004
604 JOINT STIFFNESS 11 0.0004
605 BLOOD GLUCOSE DECREASED 20 0.0004
606 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
607 HEART RATE INCREASED 41 0.0004
608 FAECES SOFT 3 0.0004
609 UTERINE LEIOMYOMA 3 0.0004
610 DYSPHONIA 24 0.0004
611 DYSURIA 15 0.0004
612 CEREBRAL DISORDER 3 0.0004
613 URINARY INCONTINENCE 12 0.0004
614 HYPERCALCAEMIA 5 0.0004
615 ABDOMINAL TENDERNESS 2 0.0004
616 KETOACIDOSIS 3 0.0004
617 HYPOAESTHESIA ORAL 6 0.0004
618 EMPHYSEMA 4 0.0004
619 SLUGGISHNESS 4 0.0004
620 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
621 ROAD TRAFFIC ACCIDENT 16 0.0004
622 ABDOMINAL PAIN UPPER 78 0.0004
623 FURUNCLE 3 0.0004
624 BLOOD ALBUMIN DECREASED 3 0.0004
625 RENAL CYST 3 0.0004
626 CYSTITIS 12 0.0004
627 EYE HAEMORRHAGE 5 0.0004
628 BRUXISM 2 0.0004
629 MUSCULAR WEAKNESS 42 0.0004
630 FAECES DISCOLOURED 8 0.0004
631 PARAESTHESIA 58 0.0004
632 LYMPHADENOPATHY 13 0.0004
633 BLOOD POTASSIUM DECREASED 11 0.0004
634 HICCUPS 3 0.0004
635 SKIN LESION 10 0.0004
636 PERIPHERAL COLDNESS 5 0.0004
637 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
638 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
639 SENSATION OF FOREIGN BODY 3 0.0004
640 INFUSION SITE ERYTHEMA 3 0.0004
641 FISTULA 4 0.0004
642 BLOOD CREATININE INCREASED 23 0.0004
643 HYPOPHAGIA 9 0.0004
644 RASH PRURITIC 19 0.0004
645 SKIN DISCOLOURATION 16 0.0003
646 HYPOAESTHESIA 52 0.0003
647 MYOPATHY 3 0.0003
648 SKIN SWELLING 3 0.0003
649 ASTHENIA 129 0.0003
650 COGNITIVE DISORDER 16 0.0003
651 OFF LABEL USE 300 0.0003
652 FEELING HOT 21 0.0003
653 NIGHT SWEATS 11 0.0003
654 SPINAL PAIN 4 0.0003
655 RHINORRHOEA 22 0.0003
656 PURPURA 3 0.0003
657 AMNESIA 22 0.0003
658 RESPIRATORY RATE INCREASED 3 0.0003
659 CATARACT OPERATION 2 0.0003
660 DISTURBANCE IN ATTENTION 18 0.0003
661 ANAL INCONTINENCE 3 0.0003
662 BONE LOSS 5 0.0003
663 CHEST DISCOMFORT 34 0.0003
664 TREMOR 55 0.0003
665 COVID-19 58 0.0003
666 OPTIC NEURITIS 3 0.0003
667 CONSTIPATION 72 0.0003
668 NEURALGIA 8 0.0003
669 RETCHING 7 0.0003
670 IMPAIRED WORK ABILITY 7 0.0003
671 LIVER FUNCTION TEST INCREASED 7 0.0003
672 SLEEP DISORDER 23 0.0003
673 RECTAL HAEMORRHAGE 14 0.0003
674 NERVOUSNESS 17 0.0003
675 NERVE COMPRESSION 3 0.0003
676 PHARYNGITIS 4 0.0003
677 PAIN IN JAW 9 0.0003
678 URINARY TRACT INFECTION 54 0.0003
679 MUSCLE ATROPHY 4 0.0003
680 ABSCESS 5 0.0003
681 SNEEZING 7 0.0003
682 HYPERCHOLESTEROLAEMIA 3 0.0003
683 HEART RATE IRREGULAR 7 0.0003
684 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
685 HEPATOMEGALY 3 0.0003
686 NEPHROLITHIASIS 14 0.0003
687 LABORATORY TEST ABNORMAL 9 0.0003
688 GASTRITIS 8 0.0003
689 BLADDER DISORDER 3 0.0003
690 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
691 SPINAL FRACTURE 6 0.0003
692 PRODUCT ADMINISTRATION ERROR 6 0.0003
693 ABDOMINAL PAIN 69 0.0003
694 BLOOD BILIRUBIN INCREASED 8 0.0003
695 TOOTH ABSCESS 3 0.0003
696 IMPAIRED GASTRIC EMPTYING 4 0.0003
697 ABNORMAL LOSS OF WEIGHT 2 0.0003
698 RIB FRACTURE 6 0.0003
699 BLOOD PRESSURE FLUCTUATION 7 0.0003
700 INFLAMMATION 15 0.0003
701 SYNCOPE 29 0.0003
702 FEELING ABNORMAL 69 0.0003
703 APHONIA 4 0.0003
704 DEMENTIA 8 0.0003
705 CARPAL TUNNEL SYNDROME 4 0.0003
706 INCONTINENCE 3 0.0003
707 PANCREATITIS 15 0.0003
708 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
709 INSOMNIA 75 0.0003
710 LOSS OF CONSCIOUSNESS 36 0.0003
711 JOINT INJURY 6 0.0003
712 THERAPEUTIC RESPONSE DECREASED 17 0.0003
713 VAGINAL HAEMORRHAGE 12 0.0003
714 DYSSTASIA 8 0.0003
715 TOOTH FRACTURE 3 0.0003
716 FOOT DEFORMITY 3 0.0003
717 URINARY RETENTION 9 0.0003
718 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
719 MALNUTRITION 3 0.0003
720 MIDDLE INSOMNIA 5 0.0003
721 ATRIAL FIBRILLATION 26 0.0003
722 GAIT DISTURBANCE 51 0.0003
723 IRRITABILITY 16 0.0003
724 BREAST TENDERNESS 2 0.0003
725 CHILLS 31 0.0003
726 SCAB 3 0.0003
727 MICTURITION URGENCY 3 0.0003
728 MUSCULOSKELETAL STIFFNESS 23 0.0003
729 FEELING JITTERY 5 0.0003
730 INCREASED APPETITE 5 0.0003
731 NEOPLASM 3 0.0003
732 POST PROCEDURAL COMPLICATION 5 0.0003
733 WEIGHT INCREASED 58 0.0003
734 MUSCULOSKELETAL CHEST PAIN 4 0.0003
735 ELECTROLYTE IMBALANCE 3 0.0003
736 ARTHRALGIA 107 0.0003
737 RASH 112 0.0003
738 SEXUAL DYSFUNCTION 3 0.0003
739 BACK PAIN 59 0.0003
740 SINUSITIS 26 0.0003
741 BLOOD IRON DECREASED 3 0.0003
742 HEAD INJURY 8 0.0003
743 NEUROPATHY PERIPHERAL 24 0.0003
744 ULCER 4 0.0003
745 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
746 ATRIAL FLUTTER 2 0.0003
747 WRIST FRACTURE 3 0.0003
748 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
749 PRURITUS 96 0.0002
750 PANIC ATTACK 9 0.0002
751 HYPERSOMNIA 7 0.0002
752 ABNORMAL FAECES 2 0.0002
753 CHOLELITHIASIS 8 0.0002
754 CARDIOMEGALY 3 0.0002
755 HERPES ZOSTER 14 0.0002
756 SPINAL OPERATION 3 0.0002
757 PRODUCT PREPARATION ERROR 5 0.0002
758 ABNORMAL WEIGHT GAIN 3 0.0002
759 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
760 VOMITING 113 0.0002
761 PERIPHERAL SWELLING 37 0.0002
762 DYSPNOEA EXERTIONAL 9 0.0002
763 HOT FLUSH 18 0.0002
764 ATRIAL SEPTAL DEFECT 2 0.0002
765 KNEE ARTHROPLASTY 5 0.0002
766 CANDIDA INFECTION 4 0.0002
767 SWELLING 22 0.0002
768 EATING DISORDER 5 0.0002
769 MYDRIASIS 3 0.0002
770 SCAR 4 0.0002
771 HYPERHIDROSIS 30 0.0002
772 MUSCULOSKELETAL DISCOMFORT 4 0.0002
773 SKIN CANCER 5 0.0002
774 CHEST PAIN 43 0.0002
775 CARDIAC MURMUR 2 0.0002
776 STOMATITIS 14 0.0002
777 PRODUCTIVE COUGH 11 0.0002
778 PLATELET COUNT INCREASED 3 0.0002
779 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
780 RASH MACULAR 8 0.0002
781 SOMNOLENCE 46 0.0002
782 DRUG INEFFECTIVE 301 0.0002
783 ANHEDONIA 6 0.0002
784 BEDRIDDEN 3 0.0002
785 ORAL CANDIDIASIS 3 0.0002
786 PULMONARY CONGESTION 3 0.0002
787 DEPRESSED MOOD 12 0.0002
788 SKIN EXFOLIATION 19 0.0002
789 INFLUENZA 25 0.0002
790 GASTROENTERITIS VIRAL 4 0.0002
791 RESTLESS LEGS SYNDROME 4 0.0002
792 BONE DISORDER 4 0.0002
793 FALL 73 0.0002
794 OSTEOPOROSIS 9 0.0002
795 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
796 DEEP VEIN THROMBOSIS 14 0.0002
797 MASS 3 0.0002
798 PAIN IN EXTREMITY 63 0.0002
799 DEPRESSION 48 0.0002
800 MUSCULOSKELETAL DISORDER 4 0.0002
801 FUNGAL INFECTION 7 0.0002
802 SKIN DISORDER 7 0.0002
803 MOBILITY DECREASED 15 0.0002
804 ERUCTATION 4 0.0002
805 INFLUENZA LIKE ILLNESS 17 0.0002
806 SURGERY 12 0.0002
807 BRONCHITIS 15 0.0002
808 WHEEZING 12 0.0002
809 DISORIENTATION 8 0.0002
810 PULMONARY MASS 3 0.0002
811 SWELLING FACE 13 0.0002
812 APHASIA 6 0.0002
813 CELLULITIS 10 0.0002
814 MALAISE 87 0.0002
815 SKIN ULCER 5 0.0002
816 BASAL CELL CARCINOMA 3 0.0002
817 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
818 HEPATIC ENZYME INCREASED 13 0.0002
819 SEIZURE 22 0.0002
820 HALLUCINATION, AUDITORY 3 0.0002
821 POOR QUALITY SLEEP 4 0.0002
822 HAEMOGLOBIN DECREASED 19 0.0002
823 BIPOLAR DISORDER 2 0.0002
824 MOOD ALTERED 5 0.0002
825 HYPERSENSITIVITY 34 0.0002
826 MEMORY IMPAIRMENT 25 0.0002
827 DENTAL CARIES 2 0.0002
828 LIP SWELLING 6 0.0002
829 COAGULOPATHY 3 0.0002
830 URTICARIA 30 0.0002
831 PERICARDITIS 3 0.0002
832 RENAL IMPAIRMENT 15 0.0002
833 THROAT IRRITATION 8 0.0002
834 ARTHRITIS 14 0.0002
835 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
836 THERAPY CESSATION 9 0.0002
837 PARANOIA 3 0.0002
838 ACUTE MYOCARDIAL INFARCTION 5 0.0002
839 COVID-19 PNEUMONIA 2 0.0002
840 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
841 NASOPHARYNGITIS 31 0.0002
842 COUGH 47 0.0002
843 GOUT 3 0.0002
844 OSTEOMYELITIS 3 0.0002
845 LOCALISED INFECTION 4 0.0002
846 C-REACTIVE PROTEIN INCREASED 6 0.0002
847 ADRENAL INSUFFICIENCY 2 0.0002
848 LIVER INJURY 4 0.0002
849 THROMBOSIS 13 0.0002
850 THINKING ABNORMAL 3 0.0002
851 APPLICATION SITE IRRITATION 2 0.0002
852 CARDIAC DISORDER 15 0.0002
853 SWOLLEN TONGUE 5 0.0002
854 PULMONARY EMBOLISM 15 0.0002
855 PROTEINURIA 3 0.0002
856 MOOD SWINGS 5 0.0002
857 PRODUCT DOSE OMISSION ISSUE 46 0.0002
858 LOWER LIMB FRACTURE 3 0.0002
859 ERYTHEMA 32 0.0002
860 HERNIA 3 0.0002
861 ORAL HERPES 3 0.0002
862 SKIN FISSURES 3 0.0002
863 STAPHYLOCOCCAL INFECTION 5 0.0002
864 RENAL DISORDER 7 0.0002
865 DYSPNOEA 84 0.0001
866 THROAT TIGHTNESS 4 0.0001
867 ARRHYTHMIA 7 0.0001
868 LIMB INJURY 4 0.0001
869 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
870 TACHYCARDIA 13 0.0001
871 CORONARY ARTERY OCCLUSION 2 0.0001
872 ARTHROPATHY 8 0.0001
873 COORDINATION ABNORMAL 2 0.0001
874 HYPERKALAEMIA 5 0.0001
875 CONFUSIONAL STATE 23 0.0001
876 HYPONATRAEMIA 8 0.0001
877 CEREBROVASCULAR ACCIDENT 24 0.0001
878 FLATULENCE 8 0.0001
879 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
880 GLOSSODYNIA 3 0.0001
881 RESPIRATORY DISORDER 4 0.0001
882 SPEECH DISORDER 7 0.0001
883 PANCREATITIS ACUTE 3 0.0001
884 CHROMATURIA 3 0.0001
885 DYSARTHRIA 5 0.0001
886 CORONARY ARTERY DISEASE 4 0.0001
887 PERICARDIAL EFFUSION 3 0.0001
888 ANKLE FRACTURE 2 0.0001
889 DELUSION 2 0.0001
890 ANAPHYLACTIC REACTION 7 0.0001
891 ABDOMINAL DISTENSION 13 0.0001
892 FIBROMYALGIA 3 0.0001
893 PRESYNCOPE 3 0.0001
894 BACK DISORDER 2 0.0001
895 IMPAIRED HEALING 4 0.0001
896 VISUAL ACUITY REDUCED 4 0.0001
897 VIRAL INFECTION 4 0.0001
898 ABDOMINAL PAIN LOWER 3 0.0001
899 INCORRECT DOSE ADMINISTERED 27 0.0001
900 CARDIOVASCULAR DISORDER 3 0.0001
901 HEPATITIS 3 0.0001
902 HAEMATURIA 4 0.0001
903 DELIRIUM 4 0.0001
904 HYPOTENSION 23 0.0001
905 MUCOSAL INFLAMMATION 3 0.0001
906 COLD SWEAT 2 0.0001
907 LIVER DISORDER 5 0.0001
908 FEAR 3 0.0001
909 PAIN OF SKIN 3 0.0001
910 OEDEMA 6 0.0001
911 HYPOKALAEMIA 5 0.0001
912 MENTAL STATUS CHANGES 3 0.0001
913 CONJUNCTIVITIS 2 0.0001
914 HAEMOPTYSIS 3 0.0001
915 ASTHMA 12 0.0001
916 CHRONIC KIDNEY DISEASE 8 0.0001
917 CHOKING 2 0.0001
918 BONE PAIN 6 0.0001
919 BURNING SENSATION 7 0.0001
920 JOINT SWELLING 12 0.0001
921 FLUID RETENTION 5 0.0001
922 NEUTROPHIL COUNT DECREASED 4 0.0001
923 INJECTION SITE RASH 3 0.0001
924 ECZEMA 5 0.0001
925 HIP FRACTURE 3 0.0001
926 TREATMENT NONCOMPLIANCE 5 0.0001
927 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
928 OEDEMA PERIPHERAL 11 0.0001
929 SEPSIS 10 0.0001
930 PYREXIA 31 0.0001
931 THROMBOCYTOPENIA 10 0.0001
932 OXYGEN SATURATION DECREASED 5 0.0001
933 FLUSHING 9 0.0001
934 GASTRIC DISORDER 3 0.0001
935 HAEMORRHAGE 9 0.0001
936 ACUTE KIDNEY INJURY 13 0.0001
937 COMA 4 0.0001
938 CEREBRAL HAEMORRHAGE 3 0.0001
939 RASH ERYTHEMATOUS 4 0.0001
940 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
941 HYPOGLYCAEMIA 4 0.0001
942 RESTLESSNESS 3 0.0001
943 CEREBRAL INFARCTION 2 0.0001
944 HEPATIC FUNCTION ABNORMAL 3 0.0001
945 INTESTINAL OBSTRUCTION 3 0.0001
946 SUICIDAL IDEATION 7 0.0001
947 ABNORMAL BEHAVIOUR 3 0.0001
948 RENAL FAILURE 10 0.0001
949 PNEUMONIA 24 0.0001
950 PSORIATIC ARTHROPATHY 3 0.0001
951 ANAEMIA 14 0.0001
952 DRUG INTOLERANCE 7 0.0001
953 ABNORMAL DREAMS 2 0.0001
954 INFECTION 10 0.0001
955 MENTAL DISORDER 3 0.0001
956 PULMONARY OEDEMA 3 0.0001
957 ACNE 5 0.0001
958 PLATELET COUNT DECREASED 7 0.0001
959 BONE DENSITY DECREASED 2 0.0001
960 NEOPLASM MALIGNANT 4 0.0001
961 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
962 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
963 DERMATITIS ATOPIC 3 0.0001
964 CRYING 2 0.0001
965 AGITATION 4 0.0001
966 BREAST CANCER 5 0.0001
967 HALLUCINATION 4 0.0001
968 RHEUMATOID ARTHRITIS 6 0.0001
969 PLEURAL EFFUSION 3 0.0000
970 TREATMENT FAILURE 4 0.0000
971 PSORIASIS 6 0.0000
972 MYOCARDIAL INFARCTION 8 0.0000
973 INTENTIONAL PRODUCT MISUSE 4 0.0000
974 HOSPITALISATION 7 0.0000
975 NO ADVERSE EVENT 8 0.0000
976 SKIN BURNING SENSATION 3 0.0000
977 INJECTION SITE BRUISING 3 0.0000
978 CARDIAC FAILURE 3 0.0000
979 CARDIAC FAILURE CONGESTIVE 3 0.0000
980 DEATH 32 0.0000
981 BLISTER 2 0.0000
982 TOXICITY TO VARIOUS AGENTS 5 0.0000
983 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
984 INJECTION SITE PAIN 5 0.0000
985 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000